GURVINDER SETHI MD NPI 1891884946

NPI Details

Gurvinder Sethi, MD is a hematology and oncology internal medicine in Middletown, NY with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Gurvinder Sethi, MD NPI is 1891884946. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

155 CRYSTAL RUN RD
MIDDLETOWN, NY
ZIP 10941-028
Phone: (845) 703-6999
Fax: (845) 703-6297

The NPI 1891884946 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Magnesium level (HCPCS:83735)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Unclassified drugs (HCPCS:J3490)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Ferritin (blood protein) level (HCPCS:82728)
• Blood test, clotting time (HCPCS:85610)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Red blood count, automated test (HCPCS:85045)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Folic acid level, serum (HCPCS:82746)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Albumin (protein) level (HCPCS:82040)
• Bilirubin level, total (HCPCS:82247)
• Total protein level, blood (HCPCS:84155)
• Liver enzyme (sgot), level (HCPCS:84450)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Phosphatase (enzyme) level, alkaline (HCPCS:84075)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)

The enumeration date for this NPI number is 10/12/2006 and was last updated on 12/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.